Scholar Rock aims for a 2025 launch of apitegromab in SMA, expecting $2 billion in global revenue and significant growth from upcoming trials and favorable data.
Imagine stepping into your backyard and being greeted by the soothing sound of cascading water. A backyard waterfall can transform an ordinary outdoor area into a serene oasis, offering a perfect ...